PRKAA1 and diabetic cardiomyopathy: By extrapolation, knowing that it has been suggested that the loss of AC5 protects against diabetic cardiomyopathy [40], this effect of AMPK on AC5 expression could participate in the cardioprotective effect of metformin, an AMPK activator, in diabetes models [41].